High-performance liquid chromatographic procedures for the analysis of carboplatin in human plasma and urine
- 1 April 1986
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 16 (3) , 201-206
- https://doi.org/10.1007/bf00293978
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Phase I clinical and pharmacologic trial of carboplatin daily for 5 days.1984
- PHARMACOKINETICS OF CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM(II) IN PATIENTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION1984
- PHARMACOKINETICS AND DOSAGE REDUCTION OF CIS-DIAMMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM IN PATIENTS WITH IMPAIRED RENAL-FUNCTION1984
- Clinical Pharmacokinetics of Diammine [1,1-Cydobutanedicarboxylato (2-)]-0,0′-Platinum (CBDCA)Published by Springer Nature ,1984
- Phase I study of carboplatin given on a five-day intravenous schedule.Journal of Clinical Oncology, 1983
- A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).1983
- Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum IICancer Chemotherapy and Pharmacology, 1982
- EFFECTS OF 2ND-GENERATION PLATINUM ANALOGS ON ISOLATED PM-2 DNA AND THEIR CYTO-TOXICITY INVITRO AND INVIVO1980
- Selection of potential second generation platinum compoundsBiochimie, 1978